Dopamine agonists in heart failure: an untimely death.

Suppr

超能文献

作者信息

Smit A J, Girbes A R

出版信息

Neth J Med. 1997 Nov;51(5):151-3. doi: 10.1016/s0300-2977(97)00061-2.

DOI:10.1016/s0300-2977(97)00061-2

PMID:9455093

Abstract

摘要

相似文献

Dopamine agonists in heart failure: an untimely death.

Neth J Med. 1997 Nov;51(5):151-3. doi: 10.1016/s0300-2977(97)00061-2.

Treatment of mild heart failure: the place of diuretics and ibopamine.

Eur Heart J. 1997 May;18(5):712-4. doi: 10.1093/oxfordjournals.eurheartj.a015334.

PRIME II (Second Prospective Randomized Study of Ibupamine on Mortality and Efficacy): another disappointment in heart failure therapy.

Eur Heart J. 1997 Oct;18(10):1519-20. doi: 10.1093/oxfordjournals.eurheartj.a015126.

Ibopamine and survival in severe congestive heart failure: PRIME II.

Lancet. 1997 Jul 12;350(9071):147-8. doi: 10.1016/s0140-6736(05)61858-2.

Risk factors for mortality in users of ibopamine.

Br J Clin Pharmacol. 1998 Jul;46(1):71-7. doi: 10.1046/j.1365-2125.1998.00046.x.

A nested case-control study on mortality in users of ibopamine.

Neth J Med. 1997 Nov;51(5):163-8. doi: 10.1016/s0300-2977(97)00053-3.

Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME II) Investigators.

Lancet. 1997 Apr 5;349(9057):971-7. doi: 10.1016/s0140-6736(96)10488-8.

Treating chronic heart failure: time to take stock.

Lancet. 1997 Apr 5;349(9057):966-7. doi: 10.1016/S0140-6736(97)22014-3.

[Ibopamine: the message, the messenger and the need of pharmacoepidemiological research].

Ned Tijdschr Geneeskd. 1996 Apr 13;140(15):848-50.

[Clinical efficacy of oral dopaminergic agents: new findings].

Cardiologia. 1995 Dec;40(12 Suppl 1):131-8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验